BÜHLMANN IBDoc® is not available for sale in the US.
Health Canada Licence: 98903, Device class: 3
IBDoc® is the first self testing application for fecal calprotectin in IBD patients. Based on BÜHLMANN’s long lasting experience with calprotectin assays, IBDoc® allows IBD patients for convenient self testing of fecal calprotectin. CALEX® Valve has been developed for simple and easy-to-handle stool extraction. The incorporated valve allows the precise application of 60 µl onto the test cassette. The CalApp® smart phone application is available for iOS and Android transforms smartphones into a test cassette reader.
The product can be purchased in Canada (not in the US) and requires the creation of a clinical account in charge of monitoring their patients. This is part of our concept to ensure professional monitoring of results and a clinical follow-up if results are positive. The clinic/doctor is responsible in purchasing the IBDoc® Kits that are then distributed to the individual patients.
For further information, visit www.ibdoc.net or see the US and Canada tabs below.